Suchergebnisse
Katalog
Mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Art der Quelle
Thema
- immunology 9 Treffer
- pharmaceuticals 9 Treffer
- therapeutics 9 Treffer
- government agencies offices and entities 8 Treffer
- biotechnology 6 Treffer
-
45 weitere Werte:
- bladder cancer 6 Treffer
- business 6 Treffer
- diagnostics and screening 6 Treffer
- fda actions 6 Treffer
- clinical trials and studies 5 Treffer
- patent application 5 Treffer
- patent applications 5 Treffer
- regulatory agencies 5 Treffer
- fda 4 Treffer
- post-trial research 4 Treffer
- risk and prevention 4 Treffer
- technology 4 Treffer
- u.s. food and drug administration 4 Treffer
- clinical research 3 Treffer
- enzymes and coenzymes 3 Treffer
- internet publishing 3 Treffer
- lung diseases and conditions 3 Treffer
- proteins 3 Treffer
- ractigen therapeutics 3 Treffer
- united states. food & drug administration 3 Treffer
- viral 3 Treffer
- alzheimer disease 2 Treffer
- aminotransferase 2 Treffer
- antibodies 2 Treffer
- autoantibodies 2 Treffer
- biomarkers 2 Treffer
- bioscience 2 Treffer
- blood proteins 2 Treffer
- brain diseases and conditions 2 Treffer
- cancer gene therapy 2 Treffer
- cancer therapy 2 Treffer
- central nervous system diseases and conditions 2 Treffer
- chemicals 2 Treffer
- clinical medicine 2 Treffer
- consumer goods companies 2 Treffer
- coronavirus 2 Treffer
- covid-19 2 Treffer
- dementia 2 Treffer
- drug delivery 2 Treffer
- drug delivery systems 2 Treffer
- electronics 2 Treffer
- fusion proteins 2 Treffer
- gene therapy 2 Treffer
- healthcare technology companies 2 Treffer
- high voltage 2 Treffer
Sprache
Inhaltsanbieter
10 Treffer
-
In: Medical Letter on the CDC & FDA, 2024-02-16, S. 636-636serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-01-30, S. 78-78serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2023-12-01, S. 790-790serialPeriodicalZugriff:
-
Ractigen Therapeutics Secures FDA Fast Track Designation for RAG-01, a First-in-Class saRNA Therapy.In: Medical Letter on the CDC & FDA, 2024-06-03, S. 34-34serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-05-10, S. 26-26serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-05-10, S. 702-702serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-02-11, S. 1433-1433serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2023-11-14, S. 1958-1958serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2023-07-31, S. 560-560serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2023-04-04, S. 702-702serialPeriodicalZugriff: